HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rene A Castañeda-Cervantes Selected Research

Immunomodulation

5/2009Intravenous daclizumab for recalcitrant ocular inflammatory disease.
12/2008Flare-up rates with bimatoprost therapy in uveitic glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rene A Castañeda-Cervantes Research Topics

Disease

1Fatigue
05/2009
1Nausea
05/2009
1Pain (Aches)
05/2009
1Inflammation (Inflammations)
05/2009
1Uveitis
12/2008
1Glaucoma
12/2008

Drug/Important Bio-Agent (IBA)

1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2009
1Daclizumab (Zenapax)FDA Link
05/2009
1Bimatoprost (Lumigan)FDA Link
12/2008

Therapy/Procedure

2Immunomodulation
05/2009 - 12/2008
2Therapeutics
05/2009 - 12/2008